NVCR
NVCR
JE00BYSS4X48
NovoCure Limited
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 655.353.000 605.220.000
8.3%
Cost of Revenue 166.879.000 137.181.000
21.6%
Gross Profit 488.474.000 468.039.000
4.4%
642.274.000 638.535.000
0.6%
Operating Income -153.800.000 -170.496.000
9.8%
Pretax Income -136.250.000 -131.162.000
3.9%
Net Income Common Stockholders -136.227.000 -168.627.000
19.2%
-- --
--
-- --
--
ende